Lipodystrophies and the metabolic syndrome

Journal of the American Academy of Dermatology

Volumn 59, Issue 5, 2008, Pages 887-888

  Heymann, Warren R ^a  

^a Based on the dialogue New insights into fat physiology and lipodystrophy between Alison S Avram   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENOTYPE PHENOTYPE CORRELATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X;

EID: 53349160141     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.03.022     Document Type: Article

References (6)

1. Capell B.C., and Collins F.S. Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 7 (2006) 940-952
2. Hegele R.A., Joy T.R., Al-Attar S.A., and Rutt B.K. Thematic review series: adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 48 (2007) 1433-1444
3. Hegele R.A., and Oshima J. Phenomics and lamins: from disease to therapy. Exp Cell Res 313 (2007) 2134-2143
4. Owen K.R., Donohoe M., Ellard S., Clarke T.J., Nicholls A.J., Hattersley A.T., and Bingham C. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobbberling syndrome). Nephron Clin Pract 96 2 (2004) c35-c38
5. Maraldi N.M., Capanni C., Mattioli E., Columbaro M., Squarzoni S., Parnaik W.K., et al. A pathogenic mechanism leading to partial lipodystrophy and prospects for pharmacological treatment of insulin resistance syndrome. Acta Biomed 78 Suppl 1 (2007) 207-215
6. Guettier J.M., Park J.Y., Cochran E.K., Poitou C., Basdevant A., Meier M., et al. Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation. Clin Endocrinol (Oxf) 68 (2008) 547-554